Portrait of Mullin, Markwayne

Mullin, Markwayne

U.S. Senator OK Republican Party

Congressional stock trade history disclosed under the STOCK Act, parsed and scored by FilingIQ.

Disclosed trades
745
Buys / sells
58% / 42%
Last trade
Feb 25, 2026
Last filing
Mar 10, 2026

Latest disclosed trades

Latest 10 of 745
Ticker Type Traded
AZO Sell Feb 25, 2026
UNH Buy Feb 25, 2026
INTU Sell Feb 25, 2026
CRS Buy Feb 4, 2026
C Buy Feb 4, 2026
GS Sell Feb 4, 2026
COHR Sell Feb 4, 2026
FCFS Buy Feb 4, 2026
MTZ Sell Feb 4, 2026
VSEC Buy Feb 4, 2026

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window, and to see the FilingIQ Score on every trade.

Mullin, Markwayne stock trade activity

FilingIQ has indexed 745 congressional stock trade disclosures for Mullin, Markwayne. The most recent disclosed transaction is dated Feb 25, 2026.

Across the full history, 430 purchases and 315 sales have been disclosed under the STOCK Act.

Top tickers traded by Mullin, Markwayne

Frequently asked

How many stock trades has Mullin, Markwayne disclosed?
FilingIQ tracks 745 Periodic Transaction Report disclosures for Mullin, Markwayne, with the most recent dated Feb 25, 2026. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Mullin, Markwayne a net buyer or net seller?
Across the disclosed trade history, 430 (58%) were purchases and 315 (42%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Mullin, Markwayne come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.